Advent Of Newer Technologies To Propel The Global Angiography Equipment Market
Market
Highlights:
Angiography is an insignificantly intrusive
procedure that is utilized to see the veins in the body. As of now, mechanical
headways in interventional radiology have prompted the advancement of
OCT-angiography, MRI-angiography, and computerized level board gadgets, which
are required to drive the market development during the examination time frame.
The global Angiography Equipment Market is estimated to pick up unmistakable quality
over the estimate time frame from 2018 to 2023. It is evaluated that the global
angiography equipment market is required to enroll a CAGR of 5.2%
during the conjecture time from 2018 to 2023.
Get a Free Sample @ https://www.marketresearchfuture.com/sample_request/6055
The rising pervasiveness of cardiovascular
ailments, expanding instances of angiography strategies, developing geriatric
populace, and advantages of the system in early determination and treatment are
significant drivers pushing the market development. For example, according to
the European Union (EU) measurements, in 2015, transluminal coronary
angioplasties were the most noteworthy performed methods in Germany with a
normal of multiple times per 100,000 occupants. Moreover, the developing
interest for Interventional Angiography Systems in negligibly intrusive medical
procedures, rising medicinal services consumption, and innovative headways are
supporting the market development. Nonetheless, the confinements in repayment
for angiographic medical procedures and the danger of radiation presentation
are significant limitations in the growth of the market.
Competitive
Analysis:
Koninklijke Philips N.V., GE Healthcare, Siemens
Healthineers, Canon Corporation, (U.S.), Cordis, Boston Scientific Corporation,
Shimadzu Corporation, Medtronic, B. Braun Melsungen, Angiodynamics, and Abbott
Laboratories.
Segmentation:
· The angiography equipment market is segmented on the basis ofthe product, technology, procedure, indication, application, and end-user.
· Based onthe product, the market is segmented as angiography equipment solutions. The angiography equipment solutions are further segmented into angiography catheters, angiography systems, Vascular Closure Devices (VCDs), angiography contrast media, angiography balloons, angiography accessories, and angiography guidewires.
· The global angiography equipment market based on technology is segmented as X-ray angiography, CT angiography, MR angiography, and other angiography technologies. Of these, X-ray angiography segment is further segmented into flat-panel detectors and image intensifiers.
· The global angiography equipment market based onthe procedure is further segmented into endovascular angiography, on-angiography, coronary angiography, neuro-angiography, and other angiography procedures.
· The global angiography equipment market based on indication is segmented into valvular heart disease, coronary artery disease,congestive heart failure, congenital heart disease, and other indications.
· On the basis of application, the market is segmented into diagnostics and therapeutics.
· Based on end-user, the market is segmented as hospitals and clinics, diagnostic and imaging centers, and research institutes.
Regional
Analysis:
Regionally, the angiography
equipment market is segmented intotheAmericas, Asia-Pacific, Europe, and Middle
East & Africa. Of these, Europe
commands the global angiography equipment market attributable to a well-created
framework, expanding predominance of cardiovascular issue, and mechanical
progressions. Also, the expanding number of angiography strategies and
expanding inclination to negligibly intrusive gadgets add to the development of
the market. Moreover, in 2015, according to the European Cardiovascular
Diseases Statistics, 11.3 million new instances of cardiovascular infections
were enrolled in Europe and 6.1 million new cases in the European Union.
Industry
News:
October 2019, Shimadzu Medical Systems USA has announced that its newest digital angiography family has received a Class III Medical Device license from Health Canada.
In 2019, a new angiography room with a state-of-the-art device for stroke treatment has received investment from the European Union (EU). The organization has invested around USD 2,42,61,380.00 in five devices.
Comments
Post a Comment